Skip to Content

LibiGel Approval Status

  • FDA approved: No
  • Brand name: LibiGel
  • Generic name: testosterone
  • Dosage form: Gel
  • Company: Antares Pharma, Inc. and BioSante Pharmaceuticals Inc.
  • Treatment for: Hypoactive Sexual Desire Disorder

LibiGel (testosterone) is a transdermal gel formulation of testosterone in development for the treatment of hypoactive sexual desire disorder.

Development Status and FDA Approval Process for LibiGel

DateArticle
Jun 21, 2010BioSante Pharmaceuticals Says FDA Advisory Committee Recommendation Against Flibanserin has No Impact on LibiGel
Oct  2, 2007Antares Reports Product Progress in Growing Women's Health Portfolio

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide